Cargando…

Characterisation of tumour-immune phenotypes and PD-L1 positivity in squamous bladder cancer

AIMS: Immune checkpoint inhibitor (ICI) therapy has become a viable treatment strategy in bladder cancer. However, treatment responses vary, and improved biomarkers are needed. Crucially, the characteristics of immune cells remain understudied especially in squamous differentiated bladder cancer (sq...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jung, Max, Rose, Michael, Knuechel, Ruth, Loeffler, Chiara, Muti, Hannah, Kather, Jakob Nikolas, Gaisa, Nadine T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9890720/ https://www.ncbi.nlm.nih.gov/pubmed/36726072 http://dx.doi.org/10.1186/s12885-023-10576-0

Ejemplares similares

Fibroblast growth factor receptor (FGFR) alterations in squamous differentiated bladder cancer: a putative therapeutic target for a small subgroup
por: Baldia, Philipp H., et al.
Publicado: (2016)

Predicting Mutational Status of Driver and Suppressor Genes Directly from Histopathology With Deep Learning: A Systematic Study Across 23 Solid Tumor Types
por: Loeffler, Chiara Maria Lavinia, et al.
Publicado: (2022)

Comparative genomic profiling of glandular bladder tumours
por: Maurer, Angela, et al.
Publicado: (2020)

Diagnostic and Prognostic Implications of FGFR3(high)/Ki67(high) Papillary Bladder Cancers
por: Geelvink, Mirja, et al.
Publicado: (2018)

Therapeutic implications of PD-L1 expression in bladder cancer with squamous differentiation
por: Morsch, Ronja, et al.
Publicado: (2020)

EGFR activity addiction facilitates anti-ERBB based combination treatment of squamous bladder cancer
por: Rose, Michael, et al.
Publicado: (2020)

Direct prediction of Homologous Recombination Deficiency from routine histology in ten different tumor types with attention-based Multiple Instance Learning: a development and validation study
por: Loeffler, Chiara Maria Lavinia, et al.
Publicado: (2023)

SWI/SNF Alterations in Squamous Bladder Cancers
por: Achenbach, Fabian, et al.
Publicado: (2020)

Classical mathematical models for prediction of response to chemotherapy and immunotherapy
por: Ghaffari Laleh, Narmin, et al.
Publicado: (2022)

The ECM Modulator ITIH5 Affects Cell Adhesion, Motility and Chemotherapeutic Response of Basal/Squamous-Like (BASQ) Bladder Cancer Cells
por: Rose, Michael, et al.
Publicado: (2021)

Epigenetic inactivation of ST6GAL1 in human bladder cancer
por: Antony, Pia, et al.
Publicado: (2014)

Progression of urothelial carcinoma in situ of the urinary bladder: a switch from luminal to basal phenotype and related therapeutic implications
por: Barth, Isabella, et al.
Publicado: (2018)

Artificial intelligence in oncology: chances and pitfalls
por: Kather, Jakob Nikolas
Publicado: (2023)

Spatial structure governs the mode of tumour evolution
por: Noble, Robert, et al.
Publicado: (2021)

Effective Radiosensitization of Bladder Cancer Cells by Pharmacological Inhibition of DNA-PK and ATR
por: Chughtai, Ahmed Ali, et al.
Publicado: (2022)

Harnessing the innate immune system and local immunological microenvironment to treat colorectal cancer
por: Kather, Jakob Nikolas, et al.
Publicado: (2019)

Feasibility of mass cytometry proteomic characterisation of circulating tumour cells in head and neck squamous cell carcinoma for deep phenotyping
por: Payne, Karl, et al.
Publicado: (2023)

Characterising the phenotypic evolution of circulating tumour cells during treatment
por: Tsao, Simon Chang-Hao, et al.
Publicado: (2018)

Evaluation of Therapeutic Targets in Histological Subtypes of Bladder Cancer
por: Wucherpfennig, Sophie, et al.
Publicado: (2021)

ARID1A-deficiency in urothelial bladder cancer: No predictive biomarker for EZH2-inhibitor treatment response?
por: Garczyk, Stefan, et al.
Publicado: (2018)

PD-L1 Expression in Muscle-Invasive Urinary Bladder Urothelial Carcinoma According to Basal/Squamous-Like Phenotype
por: Kim, Bohyun, et al.
Publicado: (2020)

ALA- and ALA-hexylester-induced protoporphyrin IX fluorescence and distribution in multicell tumour spheroids
por: Bigelow, C E, et al.
Publicado: (2001)

Characterisation of Human Tumours
por: Bazill, G. W.
Publicado: (1976)

Next Generation Imaging Techniques to Define Immune Topographies in Solid Tumors
por: Pietrobon, Violena, et al.
Publicado: (2021)

A framework for artificial intelligence in cancer research and precision oncology
por: Perez-Lopez, Raquel, et al.
Publicado: (2023)

The future landscape of large language models in medicine
por: Clusmann, Jan, et al.
Publicado: (2023)

Immune-related histologic phenotype in pretreatment tumour biopsy predicts the efficacy of neoadjuvant anti-PD-1 treatment in squamous lung cancer
por: Yuan, Pei, et al.
Publicado: (2022)

Promoter methylation of DNA damage repair (DDR) genes in human tumor entities: RBBP8/CtIP is almost exclusively methylated in bladder cancer
por: Mijnes, Jolein, et al.
Publicado: (2018)

Medical domain knowledge in domain-agnostic generative AI
por: Kather, Jakob Nikolas, et al.
Publicado: (2022)

Heterogenous NECTIN4 expression in urothelial high-risk non-muscle-invasive bladder cancer
por: Garczyk, Stefan, et al.
Publicado: (2022)

Detecting and characterising small liver tumours
por: Robinson, P. J. A.
Publicado: (2015)

Deep learning-based subtyping of gastric cancer histology predicts clinical outcome: a multi-institutional retrospective study
por: Veldhuizen, Gregory Patrick, et al.
Publicado: (2023)

Photodynamic Diagnosis For Superficial Bladder Cancer: do All Risk-Groups Profit Equally From Oncological and Economic Long-Term Results?
por: Otto, Wolfgang, et al.
Publicado: (2009)

TUMOURS OF THE BLADDER
Publicado: (1959)

Tumours of the Bladder
por: Wallace, David
Publicado: (1893)

Tumours of the Bladder
Publicado: (1903)

The Presence of Small Nerve Fibers in the Tumor Microenvironment as Predictive Biomarker of Oncological Outcome Following Partial Hepatectomy for Intrahepatic Cholangiocarcinoma
por: Bednarsch, Jan, et al.
Publicado: (2021)

PD-L1 amplification is associated with an immune cell rich phenotype in squamous cell cancer of the lung
por: Goldmann, Torsten, et al.
Publicado: (2021)

Artificial intelligence in liver diseases: Improving diagnostics, prognostics and response prediction
por: Nam, David, et al.
Publicado: (2022)

Self-supervised attention-based deep learning for pan-cancer mutation prediction from histopathology
por: Saldanha, Oliver Lester, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_lissfo6qd9303oeqeeb89cvfrl